[1]
M. Yilmaz, E. Yaşar, B. I. Ayli, E. Gok Oguz, and M. D. Ayli, “Comparison of Dapagliflozin and Empagliflozin in Patients with Type 2 Diabetes and/or Chronic Kidney Disease: A Real-World Observational Study: Dapagliflozin vs Empagliflozin”, J Eur Int Med Prof, vol. 4, no. 1, pp. 7–12, Feb. 2026.